Francisca Castillo1, Gustavo Monasterio1, Juan Pablo Ibarra1, José Guevara1, Emilio A Cafferata1,2, Emiliano Vicencio3, Cristian Cortez4, Paola Carvajal5, Rolando Vernal6,7. 1. Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Sergio Livingstone Pohlhammer 943, Independencia, 8380492, Santiago, Chile. 2. Department of Periodontology, School of Dentistry, Universidad Científica del Sur, Lima, Peru. 3. Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile. 4. Center for Genomics and Bioinformatics, Faculty of Sciences, Universidad Mayor, Santiago, Chile. 5. Department of Conservative Dentistry, Faculty of Dentistry, Universidad de Chile, Santiago, Chile. 6. Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Sergio Livingstone Pohlhammer 943, Independencia, 8380492, Santiago, Chile. rvernal@uchile.cl. 7. Department of Conservative Dentistry, Faculty of Dentistry, Universidad de Chile, Santiago, Chile. rvernal@uchile.cl.
Abstract
OBJECTIVES: During periodontitis, chronic inflammation triggers soft tissue breakdown, and hyaluronan is degraded into fragments of low molecular weight (LMW-HA). This investigation aimed to elucidate whether LMW-HA fragments with immunogenic potential on T lymphocytes remain in periodontal tissues after periodontal treatment. MATERIALS AND METHODS: GCF samples were obtained from 15 periodontitis-affected patients and the LMW-HA, RANKL, and OPG levels were analyzed before and after 6 months of periodontal treatment by ELISA. Eight healthy individuals were analyzed as controls. Besides, human T lymphocytes were purified, exposed to infected dendritic cells, and pulsed with LMW-HA. Non-treated T lymphocytes were used as control. The expression levels of the transcription factors and cytokines that determine the Th1, Th17, and Th22 lymphocyte differentiation and function were analyzed by RT-qPCR. Similarly, the expression levels of RANKL and CD44 were analyzed. RESULTS: In the GCF samples of periodontitis-affected patients, higher levels of LMW-HA were detected when compared with those of healthy individuals (52.1 ± 15.4 vs. 21.4 ± 12.2, p < 0.001), and these increased levels did not decrease after periodontal therapy (52.1 ± 15.4 vs. 45.7 ± 15.9, p = 0.158). Similarly, the RANKL levels and RANKL/OPG ratios did not change after periodontal therapy. Furthermore, in human T lymphocytes, LMW-HA induced higher expression levels of the Th1, Th17, and Th22-related transcription factors and cytokines, as well as CD44 and RANKL, as compared with non-treated cells. CONCLUSIONS: In some patients, increased levels of LMW-HA persist in periodontal tissues after conventional periodontal therapy, and these remaining LMW-HA fragments with immunostimulatory potential could induce the polarization of a pathologic Th1/Th17/Th22-pattern of immune response on T lymphocytes. CLINICAL RELEVANCE: The persistence of increased levels of LMW-HA in periodontal tissues after periodontal therapy could favor the recurrence of the disease and further breakdown of periodontal supporting tissues.
OBJECTIVES: During periodontitis, chronic inflammation triggers soft tissue breakdown, and hyaluronan is degraded into fragments of low molecular weight (LMW-HA). This investigation aimed to elucidate whether LMW-HA fragments with immunogenic potential on T lymphocytes remain in periodontal tissues after periodontal treatment. MATERIALS AND METHODS: GCF samples were obtained from 15 periodontitis-affected patients and the LMW-HA, RANKL, and OPG levels were analyzed before and after 6 months of periodontal treatment by ELISA. Eight healthy individuals were analyzed as controls. Besides, human T lymphocytes were purified, exposed to infected dendritic cells, and pulsed with LMW-HA. Non-treated T lymphocytes were used as control. The expression levels of the transcription factors and cytokines that determine the Th1, Th17, and Th22 lymphocyte differentiation and function were analyzed by RT-qPCR. Similarly, the expression levels of RANKL and CD44 were analyzed. RESULTS: In the GCF samples of periodontitis-affected patients, higher levels of LMW-HA were detected when compared with those of healthy individuals (52.1 ± 15.4 vs. 21.4 ± 12.2, p < 0.001), and these increased levels did not decrease after periodontal therapy (52.1 ± 15.4 vs. 45.7 ± 15.9, p = 0.158). Similarly, the RANKL levels and RANKL/OPG ratios did not change after periodontal therapy. Furthermore, in human T lymphocytes, LMW-HA induced higher expression levels of the Th1, Th17, and Th22-related transcription factors and cytokines, as well as CD44 and RANKL, as compared with non-treated cells. CONCLUSIONS: In some patients, increased levels of LMW-HA persist in periodontal tissues after conventional periodontal therapy, and these remaining LMW-HA fragments with immunostimulatory potential could induce the polarization of a pathologic Th1/Th17/Th22-pattern of immune response on T lymphocytes. CLINICAL RELEVANCE: The persistence of increased levels of LMW-HA in periodontal tissues after periodontal therapy could favor the recurrence of the disease and further breakdown of periodontal supporting tissues.
Authors: Kara A Scheibner; Michael A Lutz; Sada Boodoo; Matthew J Fenton; Jonathan D Powell; Maureen R Horton Journal: J Immunol Date: 2006-07-15 Impact factor: 5.422
Authors: M Hernández; N Dutzan; J García-Sesnich; L Abusleme; A Dezerega; N Silva; F E González; R Vernal; T Sorsa; J Gamonal Journal: J Dent Res Date: 2011-04-06 Impact factor: 6.116
Authors: Rita C L Martins; Claudio C Werneck; Lia A G Rocha; Eduardo J Feres-Filho; Luiz-Claudio F Silva Journal: J Periodontal Res Date: 2003-04 Impact factor: 4.419
Authors: Maria B Asparuhova; Vivianne Chappuis; Alexandra Stähli; Daniel Buser; Anton Sculean Journal: Clin Oral Investig Date: 2020-03-31 Impact factor: 3.573
Authors: Maddalena Grieco; Ornella Ursini; Ilaria Elena Palamà; Giuseppe Gigli; Lorenzo Moroni; Barbara Cortese Journal: Mater Today Bio Date: 2022-10-08